Similar articles for PMID: 8373348

Year	Number of Results
1988	1
1989	1
1991	3
1992	6
1993	9
1994	5
1995	3
1996	5
1997	10
1998	5
1999	3
2000	6
2001	3
2002	5
2003	5
2004	3
2005	2
2006	2
2007	4
2008	2
2011	2
2013	1
2014	1
2017	1
2021	1
2024	0

1

Isoenzyme specificity of bisindolylmaleimides, selective inhibitors of protein kinase C.

Wilkinson SE, Parker PJ, Nixon JS. Wilkinson SE, et al. Biochem J. 1993 Sep 1;294 ( Pt 2)(Pt 2):335-7. doi: 10.1042/bj2940335. Biochem J. 1993. PMID: 8373348 Free PMC article.

2

Acyclic N-(azacycloalkyl)bisindolylmaleimides: isozyme selective inhibitors of PKCbeta.

Faul MM, Gillig JR, Jirousek MR, Ballas LM, Schotten T, Kahl A, Mohr M. Faul MM, et al. Bioorg Med Chem Lett. 2003 Jun 2;13(11):1857-9. doi: 10.1016/s0960-894x(03)00286-5. Bioorg Med Chem Lett. 2003. PMID: 12749884

3

The bisindolylmaleimide GF 109203X is a potent and selective inhibitor of protein kinase C.

Toullec D, Pianetti P, Coste H, Bellevergue P, Grand-Perret T, Ajakane M, Baudet V, Boissin P, Boursier E, Loriolle F, et al. Toullec D, et al. J Biol Chem. 1991 Aug 25;266(24):15771-81. J Biol Chem. 1991. PMID: 1874734 Free article.

4

Kinetic analysis of protein kinase C inhibition by staurosporine: evidence that inhibition entails inhibitor binding at a conserved region of the catalytic domain but not competition with substrates.

Ward NE, O'Brian CA. Ward NE, et al. Mol Pharmacol. 1992 Feb;41(2):387-92. Mol Pharmacol. 1992. PMID: 1538715

5

Inhibitors of protein kinase C. 3. Potent and highly selective bisindolylmaleimides by conformational restriction.

Bit RA, Davis PD, Elliott LH, Harris W, Hill CH, Keech E, Kumar H, Lawton G, Maw A, Nixon JS, et al. Bit RA, et al. J Med Chem. 1993 Jan 8;36(1):21-9. doi: 10.1021/jm00053a003. J Med Chem. 1993. PMID: 8421286

6

(S)-13-[(dimethylamino)methyl]-10,11,14,15-tetrahydro-4,9:16, 21-dimetheno-1H, 13H-dibenzo[e,k]pyrrolo[3,4-h][1,4,13]oxadiazacyclohexadecene-1,3(2H)-d ione (LY333531) and related analogues: isozyme selective inhibitors of protein kinase C beta.

Jirousek MR, Gillig JR, Gonzalez CM, Heath WF, McDonald JH 3rd, Neel DA, Rito CJ, Singh U, Stramm LE, Melikian-Badalian A, Baevsky M, Ballas LM, Hall SE, Winneroski LL, Faul MM. Jirousek MR, et al. J Med Chem. 1996 Jul 5;39(14):2664-71. doi: 10.1021/jm950588y. J Med Chem. 1996. PMID: 8709095

7

Macrocyclic bisindolylmaleimides as inhibitors of protein kinase C and glycogen synthase kinase-3.

Zhang HC, White KB, Ye H, McComsey DF, Derian CK, Addo MF, Andrade-Gordon P, Eckardt AJ, Conway BR, Westover L, Xu JZ, Look R, Demarest KT, Emanuel S, Maryanoff BE. Zhang HC, et al. Bioorg Med Chem Lett. 2003 Sep 15;13(18):3049-53. doi: 10.1016/s0960-894x(03)00644-9. Bioorg Med Chem Lett. 2003. PMID: 12941331

8

Selective inhibition of protein kinase C isozymes by the indolocarbazole Gö 6976.

Martiny-Baron G, Kazanietz MG, Mischak H, Blumberg PM, Kochs G, Hug H, Marmé D, Schächtele C. Martiny-Baron G, et al. J Biol Chem. 1993 May 5;268(13):9194-7. J Biol Chem. 1993. PMID: 8486620 Free article.

9

Differential inhibition of protein kinase C isozymes by UCN-01, a staurosporine analogue.

Seynaeve CM, Kazanietz MG, Blumberg PM, Sausville EA, Worland PJ. Seynaeve CM, et al. Mol Pharmacol. 1994 Jun;45(6):1207-14. Mol Pharmacol. 1994. PMID: 8022414

10

Inhibitors of protein kinase C. 1. 2,3-Bisarylmaleimides.

Davis PD, Hill CH, Lawton G, Nixon JS, Wilkinson SE, Hurst SA, Keech E, Turner SE. Davis PD, et al. J Med Chem. 1992 Jan;35(1):177-84. doi: 10.1021/jm00079a024. J Med Chem. 1992. PMID: 1732526

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

89 results

Results by year